Kenny Kevin J.
Known title: President of Global SpineCIK: 0001520400
Associated companies
Transaction History
| OFIX | ▲ Buy | Option Exercise | 5,959 | $0 | 1/8/2024 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 1,511 | $20K | 1/8/2024 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 2,955 | $37K | 1/5/2024 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 609 | $7K | 12/4/2023 | View on chart |
| OFIX | ▼ Sell | Open Market | 3,876 | $74K | 5/26/2023 | View on chart |
| OFIX | ▼ Sell | Open Market | 4,367 | $83K | 5/24/2023 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 1,469 | $26K | 4/11/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 7,449 | $0 | 4/4/2023 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 1,956 | $33K | 4/3/2023 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 2,287 | $49K | 2/1/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 10,485 | $0 | 1/5/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 12,229 | $0 | 1/5/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 20,492 | $0 | 1/5/2023 | View on chart |
| OFIX | ▲ Buy | Grant | 29,905 | $0 | 1/5/2023 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 984 | $20K | 12/5/2022 | View on chart |
| OFIX | ▲ Buy | Grant | 14,937 | $0 | 4/11/2022 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 1,202 | $40K | 4/1/2022 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 753 | $25K | 4/1/2022 | View on chart |
| OFIX | ▲ Buy | Grant | 20,492 | $0 | 2/1/2022 | View on chart |
| OFIX | ▼ Sell | Tax Withholding | 984 | $30K | 12/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Orthofix pays $24M in damages to former executives
Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.
Orthofix pays $24M in damages to former executives. Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.